Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT05609175 Recruiting - Diabetes Clinical Trials

Investigating the Relationship Between Nocturnal Glucose Levels and Motion During Sleep

Moonwalk
Start date: February 14, 2023
Phase:
Study type: Observational

In this study the investigators will explore whether the motion during sleep of people with diabetes changes as a function of the blood glucose levels. The motion will be assessed with a radar sensor, a thermal camera, and wrist worn smartwatches. Additionally, participants will answer a short daily questionnaire. Data will be collected for 10 days and analyzed at the end of the study.

NCT ID: NCT05607576 Active, not recruiting - Diabetes Clinical Trials

Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

A single-center prospective trial on the effects of standard of care radiation exposure on the Dexcom G6 continuous glucose monitoring (CGM) device.

NCT ID: NCT05605704 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Olive Leaf Extracts in the Control of Diabet

Dia-Athr
Start date: January 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets

NCT ID: NCT05604352 Not yet recruiting - Clinical trials for Diabetes Mellitus Foot Ulcer

Safety Evaluation of the DiaSole Insole With Diabetic Foot Ulcers.

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Offloading plays an important part Diabetic foot ulcers healing. The modular design of the DiaSole would allow the offloading cavity to be changed in line with the changing ulcer dimensions. It may be possible to use the DiaSole for other causes of neuropathic foot ulcerations (such as rheumatoid arthritis), but the safety of the insole needs assessing first. There is already evidence to support the use of offloading insoles in the healing and prevention of pressure ulcers, DiaSole may be an improved insole for this purpose.

NCT ID: NCT05602532 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

Triglyceride-Glucose Index in Diabetic Nephropathy in Type 2diaberes Mellitus Patients

Start date: November 1, 2022
Phase:
Study type: Observational

The aim of the present study is to investigate the associations between the TyG index and diabetic nephropathy in patients with type2 DM .

NCT ID: NCT05601349 Completed - Diabetes Mellitus Clinical Trials

TeleEducation for Implementing a Clinical Practice Guideline For Amputees

TEFICA
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The publication of a Clinical Practice Guideline (CPG) is often not enough for its correct use in the field of health care. There are barriers to the implementation of the CPG recommendations, including those related to the lack of knowledge or skills on the part of health service providers. Strategies have been proposed to improve the implementation of the CPGs through interventions with different levels of effectiveness, such as the use of reminders, informative meetings, sending educational material, audits, among others. Some of these interventions can be carried out through Telehealth strategies, that is, with remote services. The purpose of this study is to evaluate the effectiveness of a Telehealth program to improve the implementation of the Clinical Practice Guideline for diagnosis and preoperative, intraoperative and postoperative treatment of the amputee, the prescription of the prosthesis and comprehensive rehabilitation, through strategies to publicize the recommendations included in the CPG and train doctors, reducing the barriers related to the lack of knowledge of the CPG. For this, two groups of institutions that provide health services in Antioquia will be compared, randomized according to two interventions: the socialization of the recommendations of the CPG for amputees, against a combined strategy of education through a Telehealth platform and the delivery of educational material. Compliance with prioritized recommendations of the CPG will be evaluated, related to surgical techniques, perioperative practices, the prescription of prosthetic components and referral to services that allow the comprehensive rehabilitation of the person with amputation. Additionally, the theoretical knowledge of the doctors of each participating institution before and after the interventions will be evaluated through a written test.

NCT ID: NCT05599633 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Effect of Sago-based Product on Glycaemic and Lipid Control in Diabetes

SAGODM
Start date: January 10, 2022
Phase: N/A
Study type: Interventional

This will be a parallel, randomised, double-blind, controlled trial. Upon successful screening, subjects will be randomised to either intervention arm or control arm in a ratio of 1:1. The subjects will consume either a drink containing 25g of Sarawak sago starch (intervention) or 25g of corn starch (control) in approximately 200mL of water, two times a day, before lunch and dinner for 12 weeks, in addition to a standardised dietary counselling for diabetes given by the hospital dietitian at baseline. The study endpoints will be evaluated after 12 weeks of starch consumption.

NCT ID: NCT05598203 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

Every year there is an increase in people with diabetes all over the world. Because it is a disease associated with several comorbidities and is increasing, there is a need for more effective treatments. Lifestyle changes combined with medication are the best strategies for the treatment and reduction of comorbidities. Therefore, the present study posits the hypothesis that the integration of nutritional education groups into standard treatment, within a nutrition-specialized outpatient clinic, may yield additional enhancements in health parameters among patients diagnosed with type 2 diabetes. The driving force behind this research lies in the pursuit of more effective strategies to enhance glycemic control, diminish the risk of complications, and elevate the overall quality of life for these patients. Our motivation stems from a commitment to base our interventions on scientific evidence and strive towards meaningful improvements in diabetes management outcomes. A randomized clinical trial will be conducted with adult patients with a previous diagnosis of type 2 diabetes. Patients will be divided into two groups (intervention: nutritional education added the usual care; and control: usual care). The outcomes analyzed will be: glycemic control, lipid profile, body mass and dynapenia obesity, blood pressure values, eating behavior, diabetes complications and adherence to recommendations.

NCT ID: NCT05597605 Completed - Clinical trials for Diabetes Mellitus, Type 2

The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects

Start date: September 21, 2022
Phase: N/A
Study type: Interventional

The objectives of SHINE study are to confirm the safety aspects of the SHINE SYSTEM. Moreover, the goal of this clinical investigation is the initial evaluation of sensor's performance by assessing sensor's ability to qualitatively detect the appropriate analytes in subjects with diabetes of 18 years and older.

NCT ID: NCT05596747 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus

Start date: November 30, 2022
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety of a study drug known as LY3209590 in Chinese participants with type 2 diabetes mellitus who are on a stable dose of basal insulin. Side effects and tolerability will be documented. Blood samples will be taken to assess how the body processes the study drug and the effect of the study drug on blood sugar levels. The study will last up to 18 weeks and may include 18 visits for each participant.